Compare Darling Ingredients Inc. Common Stock (DAR) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Darling Ingredients Inc. Common Stock vs Inovio Pharmaceuticals Inc — how do they compare? Darling Ingredients Inc. Common Stock trades at $61.3 (market cap $9.82B), while Inovio Pharmaceuticals Inc trades at $1.11 (market cap $112.19M). The key difference: Darling Ingredients Inc. Common Stock is far larger — about 87.5× Inovio Pharmaceuticals Inc's market cap, and Darling Ingredients Inc. Common Stock is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Darling Ingredients Inc. Common Stock for 0 Days and Inovio Pharmaceuticals Inc for 43 Days on average.
| DAR | INO | |
|---|---|---|
Market Cap | $9.82B | $112.19M |
Volume | 2,815,184 | 3,201,278 |
Sector | Consumer Staples | Health |
52-Week High | $68.34 | $2.65 |
52-Week Low | $29.91 | $0.66 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $13.83B | $83.51M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Inovio Pharmaceuticals trades at $1.155, up 2.21% today, with a bearish technical signal despite recent earnings beats. The company faces significant fundamental challenges with minimal revenue of $65,340 and substantial losses, reflected in a -130,000% net margin. Key catalyst is the October 30, 2026 FDA decision on INO-3107 for recurrent respiratory papillomatosis, with analyst consensus leaning bullish at a $2.75 price target.
Investment outlook hinges on FDA approval success; upside exists if INO-3107 gains approval, but persistent cash burn and lack of commercial revenue pose substantial risks. The stock remains speculative with high volatility expected around regulatory milestones.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Darling Ingredients Inc. Common Stock
Darling Ingredients collects and processes used cooking oil, animal by-products, and food waste. It produces ingredients and renewable fuel feedstocks from these materials.
Read more on DAR →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
